Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $171
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Johnson & Johnson (NYSE:JNJ) but lowered the price target from $174 to $171.
October 18, 2023 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Johnson & Johnson but lowered the price target from $174 to $171.
The lowering of the price target by Morgan Stanley indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Johnson & Johnson's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100